Cargando…
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
OBJECTIVE: immunotherapy with immune checkpoint inhibitors has become one of the standard therapeutic modalities for patients with advanced melanoma. Melanoma of the female lower genital tract is a rare and aggressive disease, with poor long-term clinical outcomes. To date, no study evaluated the ro...
Autores principales: | Indini, Alice, Di Guardo, Lorenza, Cimminiello, Carolina, Lorusso, Domenica, Raspagliesi, Francesco, Del Vecchio, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779609/ https://www.ncbi.nlm.nih.gov/pubmed/31576688 http://dx.doi.org/10.3802/jgo.2019.30.e94 |
Ejemplares similares
-
Current status and perspectives in immunotherapy for metastatic
melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018) -
Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract
por: Cai, Yuan-jun, et al.
Publicado: (2021) -
Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()
por: Schiavone, Maria B., et al.
Publicado: (2016) -
Editorial: Inflammation in the female genital tract
por: Berard, Alicia, et al.
Publicado: (2023) -
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study
por: Rutkowski, Piotr, et al.
Publicado: (2020)